Search International and National Patent Collections

1. (WO2018161871) IMIDAZOPYRIDINE COMPOUND AS P53-MDM2 INHIBITOR

Pub. No.:    WO/2018/161871    International Application No.:    PCT/CN2018/078010
Publication Date: Fri Sep 14 01:59:59 CEST 2018 International Filing Date: Tue Mar 06 00:59:59 CET 2018
IPC: C07D 471/04
C07D 487/04
C07D 403/00
A61K 31/4439
A61K 31/33
A61P 35/00
Applicants: LUOXIN BIOTECHNOLOGY (SHANGHAI) CO., LTD.
罗欣生物科技(上海)有限公司
SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
山东罗欣药业集团股份有限公司
MEDSHINE DISCOVERY INC.
南京明德新药研发股份有限公司
Inventors: CHEN, KEVIN X
陈新海
YAN, Xiaobing
颜小兵
LIANG, Na
梁娜
HU, Guoping
胡国平
LI, Jian
黎健
CHEN, Shuhui
陈曙辉
DONG, Jiaqiang
董加强
WANG, Tie-Lin
王铁林
Title: IMIDAZOPYRIDINE COMPOUND AS P53-MDM2 INHIBITOR
Abstract:
Disclosed is a p53-MDM2 inhibitor compound having the structure of an imidazopyridine, and particularly disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.